GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Pretax Margin %

CAMP (Camp4 Therapeutics) Pretax Margin % : -2,036.66% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Camp4 Therapeutics's Pre-Tax Income for the three months ended in Dec. 2024 was $-13.28 Mil. Camp4 Therapeutics's Revenue for the three months ended in Dec. 2024 was $0.65 Mil. Therefore, Camp4 Therapeutics's pretax margin for the quarter that ended in Dec. 2024 was -2,036.66%.

The historical rank and industry rank for Camp4 Therapeutics's Pretax Margin % or its related term are showing as below:

CAMP' s Pretax Margin % Range Over the Past 10 Years
Min: -14083.14   Med: -11013.27   Max: -4104.76
Current: -4104.76


CAMP's Pretax Margin % is ranked worse than
86.83% of 995 companies
in the Biotechnology industry
Industry Median: -127.47 vs CAMP: -4104.76

Camp4 Therapeutics Pretax Margin % Historical Data

The historical data trend for Camp4 Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Pretax Margin % Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Pretax Margin %
- -14,083.14 -7,943.40

Camp4 Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial -3,341.71 - - - -2,036.66

Competitive Comparison of Camp4 Therapeutics's Pretax Margin %

For the Biotechnology subindustry, Camp4 Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camp4 Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's Pretax Margin % falls into.


;
;

Camp4 Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Camp4 Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-51.791/0.652
=-7,943.40 %

Camp4 Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-13.279/0.652
=-2,036.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camp4 Therapeutics  (NAS:CAMP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Camp4 Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.